{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:52:31Z","timestamp":1794329551201,"version":"4.9.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41431-025-01986-8","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T11:35:24Z","timestamp":1764416124000},"page":"152-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT\/NUDT15 and thiopurines"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8796-2031","authenticated-orcid":false,"given":"Marieke J. H.","family":"Coenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-6867","authenticated-orcid":false,"given":"Marga","family":"Nijenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Soree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke J.","family":"de Boer-Veger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Buunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk-Jan","family":"Guchelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-7266","authenticated-orcid":false,"given":"Elisa J. F.","family":"Houwink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Risselada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard A. P. J. M.","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-5552","authenticated-orcid":false,"given":"Jesse J.","family":"Swen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-4789","authenticated-orcid":false,"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-9924","authenticated-orcid":false,"given":"Roos","family":"van Westrhenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera H. M.","family":"Deneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H. N.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"1986_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/clpt.2011.34","volume":"89","author":"JJ Swen","year":"2011","unstructured":"Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, et al. Pharmacogenetics: from bench to byte\u2014an update of guidelines. Clin Pharm Ther. 2011;89:662\u201373.","journal-title":"Clin Pharm Ther"},{"key":"1986_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/sj.clpt.6100507","volume":"83","author":"JJ Swen","year":"2008","unstructured":"Swen JJ, Wilting I, de, Goede AL, Grandia L, Mulder H, et al. Pharmacogenetics: from bench to byte. Clin Pharm Ther. 2008;83:781\u20137.","journal-title":"Clin Pharm Ther"},{"key":"1986_CR3","unstructured":"Royal Dutch Pharmacists Association (KNMP): Pharmacogenetic Recommendation Text. Available from: https:\/\/www.knmp.nl\/. [Accessed February 2025]."},{"key":"1986_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/cpt.1049","volume":"103","author":"JJ Swen","year":"2018","unstructured":"Swen JJ, Nijenhuis M, van Rhenen M, de Boer-Veger NJ, Buunk AM, Houwink EJF, et al. Pharmacogenetic information in clinical guidelines: the European Perspective. Clin Pharm Ther. 2018;103:795\u2013801.","journal-title":"Clin Pharm Ther"},{"key":"1986_CR5","unstructured":"European Association for Clinical Pharmacology and Therapeutics (EACPT). Available from: https:\/\/www.eacpt.eu\/. [Accessed February 2025]."},{"key":"1986_CR6","unstructured":"European Association of Hospital Pharmacists (EAHP). Available from: https:\/\/www.eahp.eu\/. [Accessed February 2025]."},{"key":"1986_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1586\/17474124.2015.1039987","volume":"9","author":"R Goldberg","year":"2015","unstructured":"Goldberg R, Irving PM. Toxicity and response to thiopurines in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2015;9:891\u2013900.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1986_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","volume":"34","author":"WR Connell","year":"1993","unstructured":"Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut. 1993;34:1081\u20135.","journal-title":"Gut"},{"key":"1986_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","volume":"36","author":"K Schmiegelow","year":"2014","unstructured":"Schmiegelow K, Nielsen SN, Frandsen TL, Nersting J. Mercaptopurine\/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol. 2014;36:503\u201317.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1986_CR10","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","volume":"16","author":"A Ansari","year":"2002","unstructured":"Ansari A, Hassan C, Duley J, Marinaki A, Shobowale-Bakre EM, Seed P, et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharm Ther. 2002;16:1743\u201350.","journal-title":"Aliment Pharm Ther"},{"key":"1986_CR11","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/ibd.21221","volume":"16","author":"B Jharap","year":"2010","unstructured":"Jharap B, Seinen ML, de Boer NK, van Ginkel JR, Linskens RK, Kneppelhout JC, et al. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts. Inflamm Bowel Dis. 2010;16:1541\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"1986_CR12","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","volume":"103","author":"JP Gisbert","year":"2008","unstructured":"Gisbert JP. Gomollon F: Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am J Gastroenterol. 2008;103:1783\u20131800.","journal-title":"Am J Gastroenterol"},{"key":"1986_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/flgastro-2020-101405","volume":"12","author":"M Gordon","year":"2021","unstructured":"Gordon M, Grafton-Clarke C, Akobeng A, Macdonald J, Chande N, Hanauer S, et al. Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn\u2019s disease: a systematic review. Frontline Gastroenterol. 2021;12:423\u201336.","journal-title":"Frontline Gastroenterol"},{"key":"1986_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","volume":"8","author":"JF Rahier","year":"2014","unstructured":"Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8:443\u201368.","journal-title":"J Crohns Colitis"},{"key":"1986_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s100380070020","volume":"45","author":"T Seki","year":"2000","unstructured":"Seki T, Tanaka T, Nakamura Y. Genomic structure and multiple single-nucleotide polymorphisms (SNPs) of the thiopurine S-methyltransferase (TPMT) gene. J Hum Genet. 2000;45:299\u2013302.","journal-title":"J Hum Genet"},{"key":"1986_CR16","unstructured":"National Center for Biotechnology Information. Homo sapiens thiopurine S-methyltransferase (TPMT), RefSeqGene (LRG_874). https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/1994123092. [Accessed October 2024]."},{"key":"1986_CR17","unstructured":"gnomAD: https:\/\/gnomad.broadinstitute.org\/gene\/ENSG00000137364?dataset=gnomad_r4."},{"key":"1986_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/FPC.0b013e32835f1cc0","volume":"23","author":"ML Appell","year":"2013","unstructured":"Appell ML, Berg J, Duley J, Evans WE, Kennedy MA, Lennard L, et al. Nomenclature for alleles of the thiopurine methyltransferase gene. Pharmacogenet Genomics. 2013;23:242\u20138.","journal-title":"Pharmacogenet Genomics"},{"key":"1986_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70017","volume":"17","author":"S Hernandez","year":"2024","unstructured":"Hernandez S, Hindorff LA, Morales J, Ramos EM, Manolio TA. Patterns of pharmacogenetic variation in nine biogeographic groups. Clin Transl Sci. 2024;17:e70017.","journal-title":"Clin Transl Sci"},{"key":"1986_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jmoldx.2022.06.007","volume":"24","author":"VM Pratt","year":"2022","unstructured":"Pratt VM, Cavallari LH, Fulmer ML, Gaedigk A, Hachad H, Ji Y, et al. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase. J Mol Diagn. 2022;24:1051\u201363.","journal-title":"J Mol Diagn"},{"key":"1986_CR21","unstructured":"National Center for Biotechnology Information. Homo sapiens nudix hydrolase 15 (NUDT15), RefSeqGene. https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/1024846744. [Accessed October 2024]."},{"key":"1986_CR22","unstructured":"gnomAD: https:\/\/gnomad.broadinstitute.org\/gene\/ENSG00000136159?dataset=gnomad_r4."},{"key":"1986_CR23","unstructured":"https:\/\/www.pharmvar.org\/gene\/NUDT15. [Accessed October 2024]."},{"key":"1986_CR24","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3324\/haematol.2020.266320","volume":"106","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, Yeoh AEJ, Moriyama T, Li CK, Kudo K, Arakawa Y, et al. An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia. Haematologica. 2021;106:2026\u20139.","journal-title":"Haematologica"},{"key":"1986_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3508","volume":"48","author":"T Moriyama","year":"2016","unstructured":"Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann FA, Zhao X, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet. 2016;48:367\u201373.","journal-title":"Nat Genet"},{"key":"1986_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S1542-3565(04)00127-2","volume":"2","author":"C Cuffari","year":"2004","unstructured":"Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2:410\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1986_CR27","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1111\/jgh.15411","volume":"36","author":"H Morikubo","year":"2021","unstructured":"Morikubo H, Kobayashi T, Ozaki R, Okabayashi S, Kuronuma S, Takeuchi O, et al. Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition. J Gastroenterol Hepatol. 2021;36:2116\u201324.","journal-title":"J Gastroenterol Hepatol"},{"key":"1986_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/bcpt.13483","volume":"128","author":"A Zimdahl Kahlin","year":"2021","unstructured":"Zimdahl Kahlin A, Helander S, Wennerstrand P, Vikingsson S, Martensson LG, Appell ML. Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism. Basic Clin Pharm Toxicol. 2021;128:52\u201365.","journal-title":"Basic Clin Pharm Toxicol"},{"key":"1986_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1067\/mcp.2000.108674","volume":"68","author":"L Yan","year":"2000","unstructured":"Yan L, Zhang S, Eiff B, Szumlanski CL, Powers M, O\u2019Brien JF, et al. Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis. Clin Pharm Ther. 2000;68:210\u20139.","journal-title":"Clin Pharm Ther"},{"key":"1986_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S1542-3565(05)00697-X","volume":"3","author":"MF Neurath","year":"2005","unstructured":"Neurath MF, Kiesslich R, Teichgr\u00e4ber U, Fischer C, Hofmann U, Eichelbaum M, et al. 6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2005;3:1007\u201314.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1986_CR31","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1080\/17425255.2021.2029406","volume":"17","author":"DS Deben","year":"2021","unstructured":"Deben DS, Wong DR, van Bodegraven AA. Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease. Expert Opin Drug Metab Toxicol. 2021;17:1433\u201344.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1986_CR32","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1371\/journal.pmed.0040209","volume":"4","author":"JJ Swen","year":"2007","unstructured":"Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 2007;4:e209.","journal-title":"PLoS Med"},{"key":"1986_CR33","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/cpt.1304","volume":"105","author":"MV Relling","year":"2019","unstructured":"Relling MV, Schwab M, Whirl-Carrillo M, Suarez-Kurtz G, Pui CH, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update. Clin Pharm Ther. 2019;105:1095\u2013105.","journal-title":"Clin Pharm Ther"},{"key":"1986_CR34","unstructured":"February 2019 and March 2024 updates of the CPIC guideline for thiopurines and TPMT and NUDT15, available from https:\/\/cpicpgx.org\/guidelines\/guideline-for-thiopurines-and-tpmt\/."},{"key":"1986_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.therap.2016.09.016","volume":"72","author":"JB Woillard","year":"2017","unstructured":"Woillard JB, Chouchana L, Picard N, Loriot MA. French Network of P: pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx). Therapie. 2017;72:285\u201399.","journal-title":"Therapie"},{"key":"1986_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.therap.2017.01.005","volume":"72","author":"S Quaranta","year":"2017","unstructured":"Quaranta S, Thomas F. Pharmacogenetics of anti-cancer drugs: state of the art and implementation - recommendations of the French National Network of Pharmacogenetics. Therapie. 2017;72:205\u201315.","journal-title":"Therapie"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01986-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01986-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01986-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:09:48Z","timestamp":1768810188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01986-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01986-8","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}